{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:26:12Z","timestamp":1790807172040,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This research aimed to explore if carnitine (CARN) deficiency is a risk factor in methotrexate (MTX)-mediated acute kidney injury (AKI) and to mechanistically reveal the potential attenuating effect of CARN against MTX-mediated nephrotoxicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Thirty-six adult male Wister albino rats were subgrouped into six groups. Groups 1, 2, and 3 received 0.9% normal saline (0.5 mL\/200 g, i.p.), mildronate (MD, 200\u00a0mg\/kg\/day, i.p.), and <jats:sc>l<\/jats:sc>-carnitine (CARN, 200\u00a0mg\/kg\/day, i.p.) for 10 uninterrupted days, respectively. Groups 4, 5, and 6 received similar doses of normal saline, MD, and CARN for 5 days prior to as well as following a solo dose of methotrexate (MTX, 20\u00a0mg\/kg, i.p.), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Treatment with a single dose of MTX significantly boosted serum nephrotoxicity as well as hepatotoxicity indices; additionally, it increased the percentage of collagen deposition in rat kidney tissues with obvious histopathological changes. Moreover, MTX lowered kidney levels of adenosine triphosphate (ATP) and amplified acetyl-CoA carboxylase-1 (ACC-1) in kidney tissues. In MD-treated rats, MTX progressively boosted nephrotoxicity indices and collagen disposition in kidney tissues as well as progressive additional reduction in ATP as compared with MTX-treated rats and serum carnitine levels compared with MD-treated rats. Carnitine administration totally counteracted the biochemical and histopathological alterations mediated by MTX to the normal measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This research proposes that carnitine deficiency is a potential risk factor in the development of MTX-mediated AKI. MTX disrupts ACC1 signaling with the consequential inhibition of ATP production. Carnitine supplementation attenuates MTX-mediated AKI. Our results are preliminary and mandate further mechanistic study to justify the progression of AKI by MTX in CARN-deficient rats.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00321-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:49:53Z","timestamp":1758883793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carnitine deficiency augments methotrexate-mediated acute renal injury in rats"],"prefix":"10.1186","volume":"37","author":[{"given":"Fatema Alaa El-Din","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Moneim M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"Karkeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat M.","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Sayed-Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"321_CR1","unstructured":"Hanoodi M, Mittal M. Methotrexate. 2023 Aug 16. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 32,310,574."},{"issue":"20","key":"321_CR2","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.3390\/ijms20205023","volume":"20","author":"Y Bedoui","year":"2019","unstructured":"Bedoui Y, Guillot X, S\u00e9lambarom J, Guiraud P, Giry C, Jaffar-Bandjee MC, Ralandison S, Gasque P. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019Oct 10;20(20):5023. https:\/\/doi.org\/10.3390\/ijms20205023. PMID: 32,310,574.","journal-title":"Int J Mol Sci"},{"key":"321_CR3","unstructured":"Mikhaylov D, Hashim PW, Nektalova T, Goldenberg G. Systemic psoriasis therapies and comorbid disease in patients with psoriasis: a review of potential risks and benefits. J Clin Aesthet Dermatol. 2019 Jun;12(6):46\u201354. Epub 2019 Jun 1. PMID: 31,360,288; PMCID: PMC6624011."},{"key":"321_CR4","doi-asserted-by":"publisher","unstructured":"Singh RK, van Haandel L, Kiptoo P, Becker ML, Siahaan TJ, Funk RS. Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model. Eur J Pharmacol. 2019;853:264\u2013274. https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.052. Epub 2019 Apr 2. PMID: 30,951,714; PMCID: PMC6500488.","DOI":"10.1016\/j.ejphar.2019.03.052"},{"issue":"2\u20133","key":"321_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12026-014-8564-6","volume":"60","author":"VC Rom\u00e3o","year":"2014","unstructured":"Rom\u00e3o VC, Lima A, Bernardes M, Canh\u00e3o H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? Immunol Res. 2014;60(2\u20133):289\u2013310. https:\/\/doi.org\/10.1007\/s12026-014-8564-6. PMID: 25,391,609.","journal-title":"Immunol Res"},{"key":"321_CR6","doi-asserted-by":"publisher","unstructured":"May J, Carson KR, Butler S, Liu W, Bartlett NL, Wagner-Johnston ND. High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis. Leuk Lymphoma. 2014 Jun;55(6):1345\u20139. https:\/\/doi.org\/10.3109\/10428194.2013.840780. Epub 2013 Nov 1. PMID: 24,004,183; PMCID: PMC4100682.","DOI":"10.3109\/10428194.2013.840780"},{"issue":"6","key":"321_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006Jun;11(6):694\u2013703. https:\/\/doi.org\/10.1634\/theoncologist.11-6-694. PMID: 16,794,248.","journal-title":"Oncologist"},{"key":"321_CR8","doi-asserted-by":"publisher","unstructured":"Wiczer T, Dotson E, Tuten A, Phillips G, Maddocks K. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity. J Oncol Pharm Pract. 2016 Jun;22(3):430\u20136. https:\/\/doi.org\/10.1177\/1078155215594417. Epub 2015 Jul 6. PMID: 26,152,702.","DOI":"10.1177\/1078155215594417"},{"key":"321_CR9","doi-asserted-by":"publisher","unstructured":"Rosolem MM, Rabello LS, Lisboa T, Caruso P, Costa RT, Leal JV, Salluh JI, Soares M. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care. 2012 Jun;27(3):301\u20137. https:\/\/doi.org\/10.1016\/j.jcrc.2011.06.014. Epub 2011 Aug 19. PMID: 21,855,281.","DOI":"10.1016\/j.jcrc.2011.06.014"},{"key":"321_CR10","doi-asserted-by":"publisher","unstructured":"Maccariello E, Valente C, Nogueira L, Bonomo H Jr, Ismael M, Machado JE, Baldotto F, Godinho M, Rocha E, Soares M. Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant. 2011 Feb;26(2):537\u201343. https:\/\/doi.org\/10.1093\/ndt\/gfq441. Epub 2010 Jul 28. PMID: 20,667,988.","DOI":"10.1093\/ndt\/gfq441"},{"issue":"2","key":"321_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ekir.2022.10.029","volume":"8","author":"S Latcha","year":"2022","unstructured":"Latcha S, Gupta M, Lin IH, Jaimes EA. High dose methotrexate-induced acute kidney injury: incidence, risk factors, and recovery. Kidney Int Rep. 2022Nov 11;8(2):360\u20134. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.029. PMID: 36,815,111; PMCID: PMC9939309.","journal-title":"Kidney Int Rep."},{"key":"321_CR12","doi-asserted-by":"publisher","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016 Dec;21(12):1471\u20131482. https:\/\/doi.org\/10.1634\/theoncologist.2015-0164. Epub 2016 Aug 5. PMID: 27,496,039; PMCID: PMC5153332.","DOI":"10.1634\/theoncologist.2015-0164"},{"key":"321_CR13","doi-asserted-by":"publisher","unstructured":"Heidari R, Ahmadi A, Mohammadi H, Ommati MM, Azarpira N, Niknahad H. Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance. Biomed Pharmacother. 2018 Nov;107:834\u2013840. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.050. Epub 2018 Aug 22. PMID: 30,142,545.","DOI":"10.1016\/j.biopha.2018.08.050"},{"key":"321_CR14","doi-asserted-by":"crossref","unstructured":"Bremer J. Carnitine in intermediary metabolism. The metabolism of fatty acid esters of carnitine by mitochondria. J Biol Chem. 1962;237:3628\u201332. PMID: 14,015,219.","DOI":"10.1016\/S0021-9258(19)84498-8"},{"key":"321_CR15","doi-asserted-by":"crossref","unstructured":"Bremer J. Carnitine in intermediary metabolism. The biosynthesis of palmitylcarnitine by cell subfractions. J Biol Chem. 1963;238:2774\u20139. PMID: 14,063,302.","DOI":"10.1016\/S0021-9258(18)67896-2"},{"key":"321_CR16","doi-asserted-by":"publisher","unstructured":"Al-Shabanah OA, Aleisa AM, Al-Yahya AA, Al-Rejaie SS, Bakheet SA, Fatani AG, Sayed-Ahmed MM. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats. Nephrol Dial Transplant. 2010;25(1):69-76. https:\/\/doi.org\/10.1093\/ndt\/gfp457. Epub 2009 Sep 8. PMID: 19737869.","DOI":"10.1093\/ndt\/gfp457"},{"key":"321_CR17","doi-asserted-by":"publisher","unstructured":"Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy. 2004;50(4):162\u201370. https:\/\/doi.org\/10.1159\/000080689. Epub 2004 Sep 3. PMID: 15,347,908.","DOI":"10.1159\/000080689"},{"issue":"4","key":"321_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5301\/JN.2011.6447","volume":"24","author":"MM Sayed-Ahmed","year":"2011","unstructured":"Sayed-Ahmed MM. l-carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues. J Nephrol. 2011;24(4):490\u20138. https:\/\/doi.org\/10.5301\/JN.2011.6447. PMID: 21,404,227.","journal-title":"J Nephrol"},{"issue":"11","key":"321_CR19","doi-asserted-by":"publisher","first-page":"e0204913","DOI":"10.1371\/journal.pone.0204913","volume":"13","author":"RA Al-Eisa","year":"2018","unstructured":"Al-Eisa RA, Al-Salmi FA, Hamza RZ, El-Shenawy NS. Role of l-carnitine in protection against the cardiac oxidative stress induced by aspartame in Wistar albino rats. PLoS One. 2018;13(11):e0204913. https:\/\/doi.org\/10.1371\/journal.pone.0204913. PMID: 30,403,670; PMCID: PMC6221268.","journal-title":"PLoS One"},{"key":"321_CR20","doi-asserted-by":"publisher","unstructured":"Volodina DE, Gureev AP, Shaforostova EA, Gryaznova MV, Ignatyeva DA, Popov VN. Effect of l-carnitine and mildronate on the mitochondrial metabolism of heart and bacterial composition of the gut microbiome in ageing mice. Life Sci. 2022 Mar 15;293:120,333. https:\/\/doi.org\/10.1016\/j.lfs.2022.120333. Epub 2022 Jan 18. PMID: 35,051,422.","DOI":"10.1016\/j.lfs.2022.120333"},{"issue":"2","key":"321_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1527-3458.2005.tb00267.x","volume":"11","author":"N Sjakste","year":"2005","unstructured":"Sjakste N, Gutcaits A, Kalvinsh I. Mildronate: an antiischemic drug for neurological indications. CNS Drug Rev. 2005;11(2):151\u201368. https:\/\/doi.org\/10.1111\/j.1527-3458.2005.tb00267.x. PMID: 16,007,237; PMCID: PMC6741751.","journal-title":"CNS Drug Rev."},{"key":"321_CR22","doi-asserted-by":"publisher","unstructured":"Shaforostova EA, Gureev AP, Volodina DE, Popov VN. Neuroprotective effect of mildronate and l-carnitine on the cognitive parameters of aged mice and mice with LPS-induced inflammation. Metab Brain Dis. 2022;37(7):2497\u20132510. https:\/\/doi.org\/10.1007\/s11011-022-01047-9. Epub 2022 Jul 26. PMID: 35,881,298.","DOI":"10.1007\/s11011-022-01047-9"},{"issue":"1","key":"321_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","volume":"25","author":"Y Shao","year":"2023","unstructured":"Shao Y, Zhang H, Shi Q, Wang Y, Liang Q. Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease. Arthritis Res Ther. 2023;25(1):159. https:\/\/doi.org\/10.1186\/s13075-023-03140-5. PMID: 37,658,422; PMCID: PMC10472585.","journal-title":"Arthritis Res Ther"},{"key":"321_CR24","doi-asserted-by":"publisher","unstructured":"Sayed-Ahmed MM. Role of carnitine in cancer chemotherapy-induced multiple organ toxicity. Saudi Pharm J. 2010;18(4):195\u2013206. https:\/\/doi.org\/10.1016\/j.jsps.2010.07.008. Epub 2010 Aug 5. PMID: 23,960,728; PMCID: PMC3730973.","DOI":"10.1016\/j.jsps.2010.07.008"},{"issue":"10","key":"321_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0006-2952(95)00019-v","volume":"49","author":"M Tsoko","year":"1995","unstructured":"Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochette L, Clouet P. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of l-carnitine by d-carnitine and a gamma-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol. 1995;49(10):1403\u201310. https:\/\/doi.org\/10.1016\/0006-2952(95)00019-v. PMID: 7,763,283.","journal-title":"Biochem Pharmacol."},{"key":"321_CR26","doi-asserted-by":"crossref","unstructured":"Spaniol M, Brooks H, Auer L, Zimmermann A, Solioz M, Stieger B, Kr\u00e4henb\u00fchl S. Development and characterization of an animal model of carnitine deficiency. Eur J Biochem. 2001;268(6):1876\u201387. PMID: 11,248,709.","DOI":"10.1046\/j.1432-1033.2001.02065.x"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/BF02005345","volume":"77","author":"DJ Paulson","year":"1982","unstructured":"Paulson DJ, Shug AL. Effects of carnitine on the ischemic arrested heart. Basic Res Cardiol. 1982;77:460\u20133. https:\/\/doi.org\/10.1007\/BF02005345.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"321_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/01.res.61.3.396","volume":"61","author":"JT Whitmer","year":"1987","unstructured":"Whitmer JT. l-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res. 1987;61(3):396\u2013408. https:\/\/doi.org\/10.1161\/01.res.61.3.396. PMID: 3,621,499.","journal-title":"Circ Res"},{"issue":"4","key":"321_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3109\/0886022X.2015.1012984","volume":"37","author":"DO Dabak","year":"2015","unstructured":"Dabak DO, Kocaman N. Effects of silymarin on methotrexate-induced nephrotoxicity in rats. Ren Fail. 2015;37(4):734\u20139.","journal-title":"Ren Fail"},{"issue":"1","key":"321_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10565-006-0025-0","volume":"22","author":"G Sener","year":"2006","unstructured":"Sener G, Ek\u015fio\u011flu-Demiralp E, Cetiner M, Ercan F, Sirvanci S, Gedik N, Ye\u011fen BC. l-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006;22(1):47\u201360.","journal-title":"Cell Biol Toxicol"},{"key":"321_CR31","unstructured":"Culling CFA. Handbook of histopathological techniques (including museum technique). 1963."},{"key":"321_CR32","doi-asserted-by":"publisher","unstructured":"Demling R, LaLonde C, Knox J, Youn YK, Zhu D, Daryani R. Fluid resuscitation with deferoxamine prevents systemic burn-induced oxidant injury. J Trauma. 1991;31(4):538\u201343; discussion 543\u20134. https:\/\/doi.org\/10.1097\/00005373-199104000-00014. PMID: 1,708,429.","DOI":"10.1097\/00005373-199104000-00014"},{"issue":"1","key":"321_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00595-004-2879-1","volume":"35","author":"G Sener","year":"2005","unstructured":"Sener G, Toklu H, Kapucu C, Ercan F, Erkanli G, Ka\u00e7maz A, Tilki M, Ye\u011fen BC. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today. 2005;35(1):52\u20139. https:\/\/doi.org\/10.1007\/s00595-004-2879-1. PMID: 15,622,465.","journal-title":"Surg Today"},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/clinchem\/25.2.336a","volume":"25","author":"A Tabacco","year":"1979","unstructured":"Tabacco A, Meiattini F, Moda E, Tarli P. Simplified enzymic\/colorimetric serum urea nitrogen determination. Clin Chem. 1979;25:336\u20137.","journal-title":"Clin Chem"},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/clinchem\/17.8.696","volume":"17","author":"DL Fabiny","year":"1971","unstructured":"Fabiny DL, Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. Clin Chem. 1971;17:696\u2013700.","journal-title":"Clin Chem."},{"key":"321_CR36","first-page":"87","volume":"31","author":"BT Doumas","year":"1971","unstructured":"Doumas BT, Watson WA, Biggs HG. Albumin standard and the measurement of serum albumin with bromocresol green Clin Chim. Acta. 1971;31:87\u201396.","journal-title":"Acta"},{"key":"321_CR37","doi-asserted-by":"publisher","unstructured":"Henry RJ, Chiamorin, Golub OJ, Berkman S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960;34:381-98. https:\/\/doi.org\/10.1093\/ajcp\/34.4_ts.381. PMID: 13713438.","DOI":"10.1093\/ajcp\/34.4_ts.381"},{"key":"321_CR38","unstructured":"Balistreri WF, Shaw LM. Liver function. In: Tietz NW, ed. Fundamentals of clinical chemistry.3 rd ed. Philadelphia:WB aunders: 1987:729-761."},{"issue":"6","key":"321_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/chrsci\/49.6.463","volume":"49","author":"J Sowell","year":"2011","unstructured":"Sowell J, Fuqua M, Wood T. Quantification of total and free carnitine in human plasma by hydrophilic interaction liquid chromatography tandem mass spectrometry. J Chromatogr Sci. 2011;49(6):463\u20138. https:\/\/doi.org\/10.1093\/chrsci\/49.6.463. PMID: 21682996.","journal-title":"J Chromatogr Sci"},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/jmcc.1994.1006","volume":"26","author":"HE Botker","year":"1994","unstructured":"Botker HE, Kimose M, Helligso P, Nielsen TT. Analytical evaluation of high-energy phosphate determination by high performance liquid chromatography in myocardial tissue. J Mol Cell Cardiol. 1994;26:41\u20138.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"321_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/FTD.0b013e31824b93a5","volume":"34","author":"MP Borgman","year":"2012","unstructured":"Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument. Ther Drug Monit. 2012;34(2):193\u20137. https:\/\/doi.org\/10.1097\/FTD.0b013e31824b93a5. PMID: 22377747.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"321_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/0974-2727.187923","volume":"9","author":"P Chavan","year":"2017","unstructured":"Chavan P, Bhat V, Karmore A, Mohite R, Waykar S, Kadu H. Establishing Syva methotrexate assay on Siemens dimension RxL analyzer: experience in a tertiary cancer care laboratory. J Lab Physicians. 2017;9(1):67\u20138. https:\/\/doi.org\/10.4103\/0974-2727.187923. PMID: 28042223; PMCID: PMC5015505.","journal-title":"J Lab Physicians."},{"key":"321_CR43","unstructured":"Chan ES, Cronstein BN. Mechanisms of action of methotrexate. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S5-8. PMID: 24,219,035."},{"issue":"3","key":"321_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","volume":"6","author":"ES Chan","year":"2010","unstructured":"Chan ES, Cronstein BN. Methotrexate\u2014how does it really work? Nat Rev Rheumatol. 2010;6(3):175\u20138. https:\/\/doi.org\/10.1038\/nrrheum.2010.5. PMID: 20,197,777.","journal-title":"Nat Rev Rheumatol"},{"key":"321_CR45","doi-asserted-by":"publisher","unstructured":"Zhao S, Wang ZP, Lin Z, Wei G, Wen X, Li S, Yang X, Zhang Q, Jing C, Dai Y, Guo J, He Y. Drug repurposing by siderophore conjugation: synthesis and biological evaluation of siderophore-methotrexate conjugates as antibiotics. Angew Chem Int Ed Engl. 2022;61(36):e202204139. https:\/\/doi.org\/10.1002\/anie.202204139. Epub 2022 Jul 25. PMID: 35,802,518.","DOI":"10.1002\/anie.202204139"},{"key":"321_CR46","doi-asserted-by":"publisher","unstructured":"Ramamoorthy SK, Hephziba R. Acute renal failure post high dose methotrexate infusion successfully managed with high dose folinic acid and high flux dialysis. Indian J Hematol Blood Transfus. 2013;29(2):90\u20132. https:\/\/doi.org\/10.1007\/s12288-011-0143-6. Epub 2012 Jan 11. PMID: 24,426,345; PMCID: PMC3636355.","DOI":"10.1007\/s12288-011-0143-6"},{"key":"321_CR47","doi-asserted-by":"crossref","unstructured":"Green MR, Chamberlain MC. Renal dysfunction during and after high-dose methotrexate. Cancer Chemother Pharmacol. 2009;63(4):599\u2013604. https:\/\/doi.org\/df92bg","DOI":"10.1007\/s00280-008-0772-0"},{"key":"321_CR48","doi-asserted-by":"crossref","unstructured":"Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity.\u00a0Oncologist. 2006;11(6):694\u2013703.\u00a0https:\/\/doi.org\/d8cgrv.","DOI":"10.1634\/theoncologist.11-6-694"},{"key":"321_CR49","doi-asserted-by":"publisher","unstructured":"Sayed-Ahmed MM. Role of carnitine in cancer chemotherapy-induced multiple organ toxicity. Saudi Pharm J. 2010;18(4):195\u2013206. https:\/\/doi.org\/10.1016\/j.jsps.2010.07.008. Epub 2010 Aug 5. PMID: 23,960,728; PMCID: PMC3730973.","DOI":"10.1016\/j.jsps.2010.07.008"},{"key":"321_CR50","doi-asserted-by":"crossref","unstructured":"Ahmad S, Thomas Robertson H, Golper TA,Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD. Multicenter trial of l-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 1990;38:912\u2013918.","DOI":"10.1038\/ki.1990.290"},{"key":"321_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s10157-010-0321-0","volume":"14","author":"MM Sayed-Ahmed","year":"2010","unstructured":"Sayed-Ahmed MM. Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model. Clin Exp Nephrol. 2010;14:418\u201326.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"321_CR52","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/kidneydial3020016","volume":"3","author":"T Ulinski","year":"2023","unstructured":"Ulinski T, Cirulli M, Virmani MA. The role of l-carnitine in kidney disease and related metabolic dysfunctions. Kidney and Dialysis. 2023;3(2):178\u201391. https:\/\/doi.org\/10.3390\/kidneydial3020016.","journal-title":"Kidney and Dialysis."},{"issue":"11","key":"321_CR53","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jat.4503","volume":"43","author":"SM Radwan","year":"2023","unstructured":"Radwan SM, Alqulaly M, Elsaeed MY, Elshora SZ, Atwa AH, Wasfey EF. l-carnitine reverses methotrexate-induced nephrotoxicity in experimental rat model: insight on SIRT1\/PGC-1\u03b1\/Nrf2\/HO-1 axis. J Appl Toxicol. 2023;43(11):1667\u201375. https:\/\/doi.org\/10.1002\/jat.4503.","journal-title":"J Appl Toxicol."},{"issue":"1","key":"321_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10565-006-0025-0","volume":"22","author":"G Sener","year":"2006","unstructured":"Sener G, Ek\u015fio\u011flu-Demiralp E, Cetiner M, Ercan F, Sirvanci S, Gedik N, Ye\u011fen BC. l-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol. 2006;22(1):47\u201360. https:\/\/doi.org\/10.1007\/s10565-006-0025-0. PMID: 16,463,019.","journal-title":"Cell Biol Toxicol"},{"key":"321_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3610417","volume":"361","author":"FM Vaz","year":"2002","unstructured":"Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J. 2002;361:417\u201329.","journal-title":"Biochem J"},{"key":"321_CR56","doi-asserted-by":"publisher","unstructured":"Radwan SM, Abdel-Latif GA, Abbas SS, Elmongy NF, Wasfey EF. The beneficial effects of l-carnitine and infliximab in methotrexate-induced hepatotoxicity: emphasis on Notch1\/Hes-1 signaling. Arch Pharm (Weinheim). 2023;356(11):e2300312. https:\/\/doi.org\/10.1002\/ardp.202300312. Epub 2023 Aug 25. PMID: 37,625,018.","DOI":"10.1002\/ardp.202300312"},{"key":"321_CR57","doi-asserted-by":"publisher","unstructured":"Golpayegani MR, Pourazar E, Yousefi G. The effectiveness of L-carnitine on improving liver enzymes in leukemic patients treated with methotrexate and 6-mercaptopurine. Int J Pediatr. 2021;9(9):14,348\u201314,354. https:\/\/doi.org\/10.22038\/ijp.2020.51230.4076.","DOI":"10.22038\/ijp.2020.51230.4076"},{"key":"321_CR58","doi-asserted-by":"publisher","unstructured":"Kadry S, Ashry M, Abuzeid N, Algaw N. Hepatotoxicity of methotrexate and the possible ameliorative effect of l-carnitine: ultrastructural study. Journal of Scientific Research in Science,\u00a02016;33(part1):307\u2013316. https:\/\/doi.org\/10.21608\/jsrs.2016.15683","DOI":"10.21608\/jsrs.2016.15683"},{"issue":"24","key":"321_CR59","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1016\/j.lfs.2005.03.029","volume":"77","author":"A Peschechera","year":"2005","unstructured":"Peschechera A, Scalibastri M, Russo F, Giarrizzo MG, Carminati P, Giannessi F, Arduini A, Ricciolini R. Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life. Life Sci. 2005Oct 28;77(24):3078\u201391. https:\/\/doi.org\/10.1016\/j.lfs.2005.03.029. Epub 2005 Jun 24 PMID: 15979102.","journal-title":"Life Sci"},{"issue":"2","key":"321_CR60","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.mehy.2006.11.049","volume":"69","author":"BX Hoang","year":"2007","unstructured":"Hoang BX, Shaw DG, Pham P, Levine S. Restoration of cellular energetic balance with l-carnitine in the neuro-bioenergetic approach for cancer prevention and treatment. Medical hypotheses. 2007;69(2):262\u201372.","journal-title":"Medical hypotheses."},{"key":"321_CR61","doi-asserted-by":"publisher","unstructured":"Y\u00fcrekli Y, Unak P, Yenisey C, Ertay T, Biber M\u00fcft\u00fcler FZ, Medine E\u0130. l-Carnitine protection against cisplatin nephrotoxicity in rats: comparison with amifostin using quantitative renal Tc 99\u2009m DMSA uptake. Mol Imaging Radionucl Ther. 2011;20(1):1\u20136. https:\/\/doi.org\/10.4274\/MIRT.20.01. Epub 2011 Apr 1. PMID: 23,486,728; PMCID: PMC3590933.","DOI":"10.4274\/MIRT.20.01"},{"issue":"138","key":"321_CR62","first-page":"546","volume":"29","author":"M Mortazavi","year":"2011","unstructured":"Mortazavi M, Asgari S, Ghassami M, Seirafian S, Taheri S, Emami Naini A, Eshaghian A, Gholamrezai A, Fayaz L, Karimi S. The effect of oral l-carnitine on serum albumin and inflammatory markers levels in patients under peritoneal dialysis: a randomized controlled trial. J Isfahan Med Sch. 2011;29(138):546\u201354.","journal-title":"J Isfahan Med Sch"},{"key":"321_CR63","doi-asserted-by":"publisher","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.01.023. Epub 2016 Jan 29. PMID: 26,828,774; PMCID: PMC4967041.","DOI":"10.1016\/j.bbamcr.2016.01.023"},{"issue":"5","key":"321_CR64","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/ijms23052717","volume":"23","author":"MA Virmani","year":"2022","unstructured":"Virmani MA, Cirulli M. The role of l-carnitine in mitochondria, prevention of metabolic inflexibility and disease initiation. Int J Mol Sci. 2022;23(5):2717. https:\/\/doi.org\/10.3390\/ijms23052717. PMID: 35,269,860; PMCID: PMC8910660.","journal-title":"Int J Mol Sci."},{"key":"321_CR65","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1172\/JCI31516","volume":"117","author":"M Claret","year":"2007","unstructured":"Claret M, Smith MA, Batterham RL, Selman C, Choudhury AI, Fryer LG, Clements M, Al-Qassab H, Heffron H, Xu AW, Speakman JR, Barsh GS, Viollet B, Vaulont S, Ashford ML, Carling D, Withers DJ. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest. 2007;117:2325\u201336. https:\/\/doi.org\/10.1172\/JCI31516.","journal-title":"J Clin Invest"},{"key":"321_CR66","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez de Morentin PB, Gonz\u00e1lez-Garc\u00eda I, Martins L, Lage R, Fern\u00e1ndez-Mallo D, Mart\u00ednez-S\u00e1nchez N, Ru\u00edz-Pino F, Liu J, Morgan DA, Pinilla L, Gallego R, Saha AK, Kalsbeek A, Fliers E, Bisschop PH, Di\u00e9guez C, Nogueiras R, Rahmouni K, Tena-Sempere M, L\u00f3pez M. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metabolism.\u00a02014;20:41\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.031.","DOI":"10.1016\/j.cmet.2014.03.031"},{"issue":"1\u20132","key":"321_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/a:1026053302036","volume":"253","author":"AK Saha","year":"2003","unstructured":"Saha AK, Ruderman NB. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem. 2003;253(1\u20132):65\u201370. https:\/\/doi.org\/10.1023\/a:1026053302036. PMID: 14,619,957.","journal-title":"Mol Cell Biochem."},{"key":"321_CR68","doi-asserted-by":"publisher","first-page":"e32656","DOI":"10.7554\/eLife.32656","volume":"7","author":"S Galic","year":"2018","unstructured":"Galic S, Loh K, Murray-Segal L, Steinberg GR, Andrews ZB, Kemp BE. AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis. Elife. 2018;7:e32656. https:\/\/doi.org\/10.7554\/eLife.32656. PMID: 29,433,631; PMCID: PMC5811211.","journal-title":"Elife."},{"key":"321_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-3-319-43589-3_2","volume":"107","author":"Y Angin","year":"2016","unstructured":"Angin Y, Beauloye C, Horman S, Bertrand L. Regulation of carbohydrate metabolism, lipid metabolism, and protein metabolism by AMPK. Exp Suppl. 2016;107:23\u201343. https:\/\/doi.org\/10.1007\/978-3-319-43589-3_2. PMID: 27,812,975.","journal-title":"Exp Suppl"},{"issue":"Pt 2","key":"321_CR70","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BST20060223","volume":"34","author":"RW Brownsey","year":"2006","unstructured":"Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM. Regulation of acetyl-CoA carboxylase. Biochem Soc Trans. 2006;34(Pt 2):223\u20137. https:\/\/doi.org\/10.1042\/BST20060223. PMID: 16,545,081.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"321_CR71","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1073\/pnas.92.9.4011","volume":"92","author":"L Abu-Elheiga","year":"1995","unstructured":"Abu-Elheiga L, Jayakumar A, Baldini A, Chirala SS, Wakil SJ. Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc Natl Acad Sci U S A. 1995;92(9):4011\u20135. https:\/\/doi.org\/10.1073\/pnas.92.9.4011. PMID: 7,732,023; PMCID: PMC42092.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"321_CR72","doi-asserted-by":"publisher","unstructured":"Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998;273(32):20,378\u201382. https:\/\/doi.org\/10.1074\/jbc.273.32.20378. PMID: 9,685,390.","DOI":"10.1074\/jbc.273.32.20378"},{"key":"321_CR73","doi-asserted-by":"publisher","unstructured":"Sayed-Ahmed MM, Aldelemy ML, Hafez MM, Al-Shabanah OA. Inhibition of gene expression of organic cation\/carnitine transporter and antioxidant enzymes in oxazaphosphorines-induced acute cardiomyopathic rat models. Oxid Med Cell Longev. 2012;2012:452902. https:\/\/doi.org\/10.1155\/2012\/452902. Epub 2012 May 30. PMID: 22701146; PMCID: PMC3369488.","DOI":"10.1155\/2012\/452902"},{"issue":"6","key":"321_CR74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/BF00548590","volume":"19","author":"TE Sand","year":"1981","unstructured":"Sand TE, Jacobsen S. Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol. 1981;19(6):453\u20136. https:\/\/doi.org\/10.1007\/BF00548590. PMID: 7,250,179.","journal-title":"Eur J Clin Pharmacol."},{"key":"321_CR75","doi-asserted-by":"publisher","unstructured":"Jafari F, Arasteh O, Hosseinjani H, Allahyari A, Ataei Azimi S, Askari VR. A critical review of methotrexate clinical interactions: role of transporters. Expert Opin Drug Metab Toxicol. 2023;19(2):91\u2013107. https:\/\/doi.org\/10.1080\/17425255.2023.2193325. Epub 2023 Mar 28. PMID: 36,946,211.","DOI":"10.1080\/17425255.2023.2193325"},{"issue":"9","key":"321_CR76","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/molecules25092127","volume":"25","author":"A Durazzo","year":"2020","unstructured":"Durazzo A, Lucarini M, Nazhand A, Souto SB, Silva AM, Severino P, Souto EB, Santini A. The nutraceutical value of carnitine and its use in dietary supplements. Molecules. 2020;25(9):2127. https:\/\/doi.org\/10.3390\/molecules25092127. PMID: 32,370,025; PMCID: PMC7249051.","journal-title":"Molecules"},{"key":"321_CR77","doi-asserted-by":"publisher","unstructured":"Pesenti G, Foppoli M, Manca D. A minimal physiologically based pharmacokinetic model for high-dose methotrexate. Cancer Chemother Pharmacol. 2021;88(4):595\u2013606. https:\/\/doi.org\/10.1007\/s00280-021-04305-2. Epub 2021 Jun 13. PMID: 34,120,234; PMCID: PMC8367929.","DOI":"10.1007\/s00280-021-04305-2"},{"key":"321_CR78","unstructured":"Steinberg SE, Campbell CL, Bleyer WA, Hillman RS. Enterohepatic circulation of methotrexate in rats in vivo. Cancer Res. 1982;42(4):1279\u201382. PMID: 7,060,005."},{"issue":"1","key":"321_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12967-025-06341-5","volume":"23","author":"F Xiang","year":"2025","unstructured":"Xiang F, Zhang Z, Xie J, Xiong S, Yang C, Liao D, Xia B, Lin L. Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation. J Transl Med. 2025;23(1):324. https:\/\/doi.org\/10.1186\/s12967-025-06341-5. PMID: 40,087,749; PMCID: PMC11907856.","journal-title":"J Transl Med."},{"key":"321_CR80","doi-asserted-by":"publisher","unstructured":"Hu C, Lancaster CS, Zuo Z, Hu S, Chen Z, Rubnitz JE, Baker SD, Sparreboom A. Inhibition of OCTN2-mediated transport of carnitine by etoposide. Mol Cancer Ther. 2012;11(4):921\u20139. https:\/\/doi.org\/10.1158\/1535-7163. MCT-11-0980. Epub 2012 Mar 2. PMID: 22,389,472; PMCID: PMC3466062.","DOI":"10.1158\/1535-7163"},{"issue":"3","key":"321_CR81","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3906\/sag-1409-39","volume":"45","author":"M Y\u00fcnc\u00fc","year":"2015","unstructured":"Y\u00fcnc\u00fc M, B\u00fck\u00fcc\u00fc N, Bayat N, Sencar L, Tarak\u00e7io\u011flu M. The effect of vitamin E and l-carnitine against methotrexate-induced injury in rat testis. Turk J Med Sci. 2015;45(3):517\u201325. https:\/\/doi.org\/10.3906\/sag-1409-39. PMID: 26,281,314.","journal-title":"Turk J Med Sci"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00321-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:49:59Z","timestamp":1758883799000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00321-y","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study has been permitted by the Research Ethics Committee (Faculty of Pharmacy, Cairo University) with approval number PT (2963).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"Prof Mohamed M. Sayed-Ahmed is a co-author and the Managing Editor of the journal and Dr Abdel Moneim M. Osman is a co-author and an Associate Editor of the journal. However, they were not involved in the editorial handling or decision-making process for this manuscript. The rest of the authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}